 Andreas Brieke
Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 19 | 2023 | 552 | 1.810 |
Why?
| | Mitral Valve Insufficiency | 7 | 2023 | 68 | 1.160 |
Why?
| | Heart Failure | 19 | 2023 | 2231 | 1.140 |
Why?
| | Mitral Valve | 5 | 2021 | 88 | 0.550 |
Why?
| | Heart Valve Prosthesis Implantation | 3 | 2023 | 180 | 0.450 |
Why?
| | Ventricular Dysfunction, Left | 7 | 2021 | 382 | 0.440 |
Why?
| | Cardiomyopathy, Dilated | 2 | 2009 | 383 | 0.430 |
Why?
| | Heart Transplantation | 5 | 2017 | 747 | 0.400 |
Why?
| | Defibrillators, Implantable | 3 | 2010 | 315 | 0.380 |
Why?
| | Arrhythmias, Cardiac | 2 | 2010 | 333 | 0.330 |
Why?
| | Cardiac Catheterization | 3 | 2023 | 527 | 0.320 |
Why?
| | Shock, Cardiogenic | 2 | 2020 | 63 | 0.310 |
Why?
| | Cardiac Pacing, Artificial | 1 | 2009 | 87 | 0.300 |
Why?
| | Restless Legs Syndrome | 1 | 2008 | 21 | 0.280 |
Why?
| | Citalopram | 1 | 2008 | 29 | 0.280 |
Why?
| | Thrombosis | 3 | 2016 | 366 | 0.280 |
Why?
| | Cocaine-Related Disorders | 1 | 2008 | 113 | 0.270 |
Why?
| | Tissue Donors | 1 | 2008 | 417 | 0.240 |
Why?
| | Hemostatics | 1 | 2022 | 52 | 0.190 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2005 | 235 | 0.190 |
Why?
| | Blood Pressure Determination | 1 | 2022 | 156 | 0.170 |
Why?
| | Treatment Outcome | 10 | 2023 | 10748 | 0.160 |
Why?
| | Mitral Valve Annuloplasty | 1 | 2019 | 4 | 0.150 |
Why?
| | Emergency Treatment | 1 | 2020 | 118 | 0.150 |
Why?
| | Stroke Volume | 4 | 2021 | 612 | 0.140 |
Why?
| | Survival Rate | 4 | 2016 | 1964 | 0.130 |
Why?
| | Humans | 33 | 2023 | 136803 | 0.130 |
Why?
| | Tropheryma | 1 | 2015 | 5 | 0.120 |
Why?
| | Whipple Disease | 1 | 2015 | 6 | 0.120 |
Why?
| | Cryosurgery | 1 | 2016 | 59 | 0.120 |
Why?
| | Heart | 1 | 2019 | 653 | 0.120 |
Why?
| | Secondary Prevention | 1 | 2016 | 233 | 0.120 |
Why?
| | Endovascular Procedures | 1 | 2019 | 315 | 0.120 |
Why?
| | Endocarditis, Bacterial | 1 | 2015 | 41 | 0.120 |
Why?
| | Follow-Up Studies | 5 | 2023 | 5106 | 0.110 |
Why?
| | Partial Thromboplastin Time | 1 | 2014 | 57 | 0.110 |
Why?
| | Male | 21 | 2023 | 67330 | 0.110 |
Why?
| | Tachycardia, Ventricular | 1 | 2016 | 175 | 0.110 |
Why?
| | Middle Aged | 16 | 2023 | 33239 | 0.100 |
Why?
| | Prosthesis Implantation | 1 | 2014 | 153 | 0.100 |
Why?
| | Female | 20 | 2023 | 72816 | 0.100 |
Why?
| | Blood Coagulation | 1 | 2014 | 255 | 0.100 |
Why?
| | Hypoxia | 1 | 2020 | 1112 | 0.100 |
Why?
| | Ventricular Function, Left | 2 | 2021 | 533 | 0.100 |
Why?
| | Disease Management | 1 | 2016 | 624 | 0.100 |
Why?
| | Aged | 11 | 2023 | 23808 | 0.100 |
Why?
| | Hiccup | 1 | 2011 | 3 | 0.090 |
Why?
| | Cyclohexanecarboxylic Acids | 1 | 2011 | 22 | 0.090 |
Why?
| | Amines | 1 | 2011 | 40 | 0.090 |
Why?
| | Vascular Stiffness | 1 | 2017 | 493 | 0.090 |
Why?
| | Calcium Channel Blockers | 1 | 2011 | 167 | 0.090 |
Why?
| | Chronic Disease | 2 | 2008 | 1786 | 0.080 |
Why?
| | Registries | 3 | 2019 | 2015 | 0.080 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2011 | 198 | 0.080 |
Why?
| | Heart Septum | 1 | 2009 | 27 | 0.080 |
Why?
| | Anticoagulants | 1 | 2014 | 664 | 0.080 |
Why?
| | Adult | 12 | 2023 | 37643 | 0.080 |
Why?
| | Safety | 1 | 2011 | 338 | 0.080 |
Why?
| | Electric Stimulation Therapy | 1 | 2010 | 81 | 0.080 |
Why?
| | Automobile Driving | 1 | 2011 | 148 | 0.080 |
Why?
| | Quality of Life | 4 | 2021 | 2878 | 0.080 |
Why?
| | Proportional Hazards Models | 2 | 2010 | 1262 | 0.070 |
Why?
| | Quality Improvement | 1 | 2016 | 1163 | 0.070 |
Why?
| | Counseling | 1 | 2011 | 388 | 0.070 |
Why?
| | Heart Rate | 2 | 2022 | 820 | 0.070 |
Why?
| | Equipment Failure | 1 | 2008 | 108 | 0.070 |
Why?
| | Myocardium | 1 | 2013 | 1001 | 0.070 |
Why?
| | Risk Assessment | 2 | 2008 | 3434 | 0.070 |
Why?
| | Thromboembolism | 1 | 2008 | 119 | 0.070 |
Why?
| | Ventricular Function, Right | 1 | 2009 | 282 | 0.070 |
Why?
| | Retrospective Studies | 6 | 2023 | 15510 | 0.060 |
Why?
| | Equipment Design | 1 | 2008 | 521 | 0.060 |
Why?
| | Myocardial Contraction | 1 | 2007 | 339 | 0.060 |
Why?
| | Aged, 80 and over | 4 | 2019 | 7593 | 0.060 |
Why?
| | Hospitalization | 3 | 2021 | 2184 | 0.060 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2007 | 323 | 0.060 |
Why?
| | Acute Disease | 1 | 2008 | 1007 | 0.060 |
Why?
| | Heart Function Tests | 1 | 2005 | 59 | 0.060 |
Why?
| | Severity of Illness Index | 2 | 2021 | 2822 | 0.060 |
Why?
| | Postoperative Complications | 1 | 2016 | 2639 | 0.060 |
Why?
| | Angiopoietin-2 | 1 | 2023 | 16 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2008 | 2052 | 0.050 |
Why?
| | Echocardiography | 2 | 2017 | 643 | 0.050 |
Why?
| | Thromboplastin | 1 | 2023 | 74 | 0.050 |
Why?
| | Kaplan-Meier Estimate | 2 | 2018 | 888 | 0.050 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2022 | 86 | 0.050 |
Why?
| | Necrosis | 1 | 2023 | 245 | 0.050 |
Why?
| | Risk Factors | 5 | 2019 | 10332 | 0.050 |
Why?
| | Prospective Studies | 3 | 2023 | 7573 | 0.050 |
Why?
| | Thrombin | 1 | 2022 | 152 | 0.050 |
Why?
| | Ultrasonography, Doppler | 1 | 2022 | 123 | 0.040 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2022 | 132 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2007 | 1772 | 0.040 |
Why?
| | Cardiotonic Agents | 1 | 2021 | 124 | 0.040 |
Why?
| | Fasting | 1 | 2002 | 280 | 0.040 |
Why?
| | Tricuspid Valve Insufficiency | 1 | 2019 | 24 | 0.040 |
Why?
| | Quality-Adjusted Life Years | 1 | 2019 | 113 | 0.040 |
Why?
| | Prognosis | 2 | 2005 | 4013 | 0.040 |
Why?
| | Incidence | 2 | 2016 | 2797 | 0.040 |
Why?
| | Intention to Treat Analysis | 1 | 2018 | 73 | 0.040 |
Why?
| | Depression | 1 | 2008 | 1397 | 0.040 |
Why?
| | Hemorrhage | 1 | 2023 | 721 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2019 | 308 | 0.040 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 1 | 1998 | 24 | 0.040 |
Why?
| | Prostheses and Implants | 1 | 2019 | 143 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2023 | 1242 | 0.040 |
Why?
| | Arterial Occlusive Diseases | 1 | 1998 | 80 | 0.040 |
Why?
| | Prosthesis Failure | 1 | 2018 | 123 | 0.030 |
Why?
| | Homocysteine | 1 | 1998 | 156 | 0.030 |
Why?
| | Heart Valve Prosthesis | 1 | 2018 | 114 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 587 | 0.030 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2020 | 291 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2018 | 1231 | 0.030 |
Why?
| | Myocardial Ischemia | 1 | 2017 | 262 | 0.030 |
Why?
| | Postoperative Care | 1 | 2017 | 261 | 0.030 |
Why?
| | Factor X | 1 | 2014 | 27 | 0.030 |
Why?
| | Blood Pressure | 1 | 2022 | 1774 | 0.030 |
Why?
| | Recovery of Function | 1 | 2019 | 652 | 0.030 |
Why?
| | United States | 3 | 2019 | 14691 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2020 | 785 | 0.030 |
Why?
| | Fatal Outcome | 1 | 2015 | 303 | 0.030 |
Why?
| | Comorbidity | 1 | 2019 | 1614 | 0.030 |
Why?
| | Hemodynamics | 1 | 2019 | 1110 | 0.030 |
Why?
| | Warfarin | 1 | 2014 | 153 | 0.030 |
Why?
| | Cardiac Surgical Procedures | 1 | 2019 | 530 | 0.030 |
Why?
| | Amino Acids, Aromatic | 1 | 2013 | 7 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2019 | 1462 | 0.030 |
Why?
| | Succinic Acid | 1 | 2013 | 37 | 0.030 |
Why?
| | Databases, Factual | 1 | 2019 | 1351 | 0.030 |
Why?
| | Percutaneous Coronary Intervention | 1 | 2018 | 478 | 0.030 |
Why?
| | Cardiomyopathies | 1 | 2017 | 348 | 0.030 |
Why?
| | Creatine | 1 | 2013 | 57 | 0.030 |
Why?
| | Heparin | 1 | 2014 | 259 | 0.020 |
Why?
| | Young Adult | 1 | 2009 | 13129 | 0.020 |
Why?
| | Glutamine | 1 | 2013 | 103 | 0.020 |
Why?
| | Antibodies | 1 | 2014 | 411 | 0.020 |
Why?
| | Alanine | 1 | 2013 | 152 | 0.020 |
Why?
| | Patient Preference | 1 | 2014 | 190 | 0.020 |
Why?
| | Blood Glucose | 1 | 2002 | 2181 | 0.020 |
Why?
| | Lactic Acid | 1 | 2013 | 305 | 0.020 |
Why?
| | Task Performance and Analysis | 1 | 2011 | 183 | 0.020 |
Why?
| | Social Support | 1 | 2014 | 616 | 0.020 |
Why?
| | Emotions | 1 | 2014 | 545 | 0.020 |
Why?
| | Patient-Centered Care | 1 | 2014 | 522 | 0.020 |
Why?
| | Colorado | 1 | 2019 | 4515 | 0.020 |
Why?
| | Tropomyosin | 1 | 2007 | 14 | 0.020 |
Why?
| | Time Factors | 1 | 2019 | 6809 | 0.020 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2007 | 38 | 0.020 |
Why?
| | Atrial Natriuretic Factor | 1 | 2007 | 57 | 0.020 |
Why?
| | Glucose | 1 | 2013 | 1019 | 0.020 |
Why?
| | Patient Acceptance of Health Care | 1 | 2014 | 805 | 0.020 |
Why?
| | Glucose Transporter Type 1 | 1 | 2007 | 50 | 0.020 |
Why?
| | Mineralocorticoid Receptor Antagonists | 1 | 2007 | 54 | 0.020 |
Why?
| | Decision Making | 1 | 2014 | 898 | 0.020 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2007 | 201 | 0.020 |
Why?
| | Myosin Heavy Chains | 1 | 2007 | 191 | 0.020 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2007 | 278 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2007 | 766 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2013 | 3540 | 0.010 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2007 | 858 | 0.010 |
Why?
| | Practice Patterns, Physicians' | 1 | 2011 | 1301 | 0.010 |
Why?
| | Glucose Intolerance | 1 | 2002 | 146 | 0.010 |
Why?
| | Physical Fitness | 1 | 2002 | 208 | 0.010 |
Why?
| | Cohort Studies | 1 | 2010 | 5704 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2002 | 1316 | 0.010 |
Why?
| | Exercise Test | 1 | 2002 | 625 | 0.010 |
Why?
| | Mesenteric Vascular Occlusion | 1 | 1998 | 6 | 0.010 |
Why?
| | Mesenteric Artery, Superior | 1 | 1998 | 15 | 0.010 |
Why?
| | Contraceptives, Oral, Combined | 1 | 1998 | 19 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2007 | 2605 | 0.010 |
Why?
| | Ileum | 1 | 1998 | 119 | 0.010 |
Why?
| | Leg | 1 | 1998 | 236 | 0.010 |
Why?
| | Ischemia | 1 | 1998 | 407 | 0.010 |
Why?
| | Diabetes Mellitus | 1 | 2002 | 1033 | 0.010 |
Why?
| | Smoking | 1 | 1998 | 1620 | 0.010 |
Why?
|
|
Brieke's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|